AU6000600A - Diagnostic method - Google Patents
Diagnostic methodInfo
- Publication number
- AU6000600A AU6000600A AU60006/00A AU6000600A AU6000600A AU 6000600 A AU6000600 A AU 6000600A AU 60006/00 A AU60006/00 A AU 60006/00A AU 6000600 A AU6000600 A AU 6000600A AU 6000600 A AU6000600 A AU 6000600A
- Authority
- AU
- Australia
- Prior art keywords
- diagnostic method
- diagnostic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9916669 | 1999-07-15 | ||
GBGB9916669.6A GB9916669D0 (en) | 1999-07-15 | 1999-07-15 | Diagnostic method |
GBGB9926293.3A GB9926293D0 (en) | 1999-11-05 | 1999-11-05 | Diagnostic method |
GB9926293 | 1999-11-05 | ||
PCT/GB2000/002741 WO2001006005A2 (en) | 1999-07-15 | 2000-07-17 | Diagnostic method comprising wt1 sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6000600A true AU6000600A (en) | 2001-02-05 |
Family
ID=26315771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU60006/00A Abandoned AU6000600A (en) | 1999-07-15 | 2000-07-17 | Diagnostic method |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1200623A2 (en) |
JP (1) | JP2003505035A (en) |
AU (1) | AU6000600A (en) |
WO (1) | WO2001006005A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1352089B1 (en) * | 2000-08-25 | 2006-12-06 | Lovelace Respiratory Research Institute | Nested methylation-specific polymerase chain reaction cancer detection method |
US20030211522A1 (en) * | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
GB0209776D0 (en) * | 2002-04-29 | 2002-06-05 | Univ Bristol | Diagnostic method |
FR2854903A1 (en) * | 2003-05-13 | 2004-11-19 | Centre Nat Rech Scient | In vitro diagnosis of cancer, based on detecting hypomethylation of deoxycytidine in CpG doublets present in specific sequences from the B melanoma antigen locus |
EP3194624B1 (en) | 2014-09-15 | 2022-02-16 | Garvan Institute of Medical Research | Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3393867B2 (en) * | 1989-11-13 | 2003-04-07 | マサチユーセツツ・インステイテユート・オブ・テクノロジー | Localization and characterization of the Wilms oncogene |
WO1999001580A1 (en) * | 1997-07-03 | 1999-01-14 | Case Western Reserve University | Compositions and methods for detection of genomic imprinting disorders |
-
2000
- 2000-07-17 AU AU60006/00A patent/AU6000600A/en not_active Abandoned
- 2000-07-17 WO PCT/GB2000/002741 patent/WO2001006005A2/en not_active Application Discontinuation
- 2000-07-17 EP EP20000946122 patent/EP1200623A2/en not_active Withdrawn
- 2000-07-17 JP JP2001511214A patent/JP2003505035A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1200623A2 (en) | 2002-05-02 |
JP2003505035A (en) | 2003-02-12 |
WO2001006005A2 (en) | 2001-01-25 |
WO2001006005A3 (en) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1173201A (en) | Skin-gripper | |
AU4784500A (en) | Reduction apparatus | |
AU1854901A (en) | Novel method | |
AU2308900A (en) | Analysis method | |
AU6105199A (en) | Diagnostic method | |
AU1163101A (en) | Diagnostic methods | |
AU5672300A (en) | Diagnostic device | |
AU3191100A (en) | Ligand-bonded complex | |
AU2194801A (en) | Diagnostic method | |
AU6000600A (en) | Diagnostic method | |
AU4416500A (en) | Tomographic system | |
AU4755800A (en) | Diagnostic system | |
AUPP612798A0 (en) | Diagnostic method | |
AU1984900A (en) | Diagnostic method | |
WO2001029756A8 (en) | Autogrid analysis | |
AU5552200A (en) | Method | |
AU1134601A (en) | Assay method | |
AU2188401A (en) | Assay method | |
AU4585100A (en) | Method | |
AUPO933597A0 (en) | Diagnostic method | |
AUPP999499A0 (en) | Software diagnostic method | |
AU1164401A (en) | Method | |
AUPR072100A0 (en) | Diagnostic method | |
AUPQ288199A0 (en) | Diagnostics | |
GB9921708D0 (en) | Diagnostic method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |